Transformative weight loss with Dulaglutide: A case report of success in a challenging patient profile of an ex-sumo wrestler.
Dulaglutide 轉變性減重:一位前相撲選手挑戰性病患案例報告的成功。
Clin Case Rep 2024-09-02
Weight Loss Effects of Glucagon-Like Peptide-One Receptor Analog Treatment in a Severely Obese Patient During Hospital Admission.
嚴重肥胖患者住院期間使用胰高血糖素樣肽-一受體類似物治療的減重效果。
Cureus 2023-03-04
Real-World Efficacy of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist, Dulaglutide, on Metabolic Parameters in Japanese Patients with Type 2 Diabetes: A Retrospective Longitudinal Study.
糖尿病日本患者中胰高血糖素樣肽-1(GLP-1) 受體激動劑 Dulaglutide 對代謝參數的實際效果:一項回顧性縱向研究。
Biomedicines 2023-03-31
Impact of Treatment with GLP1 Receptor Agonists, Liraglutide 3.0 mg and Semaglutide 1.0 mg, While on a Waiting List for Bariatric Surgery.
GLP1 受體激動劑治療對於在接受肥胖手術等待名單上的影響:Liraglutide 3.0 毫克和Semaglutide 1.0 毫克。
Biomedicines 2023-10-30
The effect of subcutaneous dulaglutide on weight loss in patients with Type 2 diabetes mellitus: Systematic review and meta-analysis of randomized controlled trials.
Subcutaneous dulaglutide對2型糖尿病患者體重減輕的影響:隨機對照試驗的系統性回顧和荟萃分析。
Eur J Clin Invest 2024-03-18
Pilot study to test the safety, tolerability and feasibility of dulaglutide during a low-energy diet for weight loss and improved glycaemic control.
測試 dulaglutide 在低熱量飲食期間對體重減輕和改善血糖控制的安全性、耐受性和可行性的初步研究。
BMJ Nutr Prev Health 2024-01-25
Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma.
Semaglutide 作為下丘腦肥胖的有前景治療:四名患有腦咽管瘤女性的六個月病例系列。
Pituitary 2024-08-01
Semaglutide Treatment in a Patient with Extreme Obesity and Massive Lymphedema: A Case Report.
極度肥胖及大規模淋巴水腫患者的 Semaglutide 治療:個案報告。
Obes Facts 2024-09-09